FRCS

Preparing Physician Leaders for the Future: AAPL, KORN FERRY Release White Paper That Details How Physician Leadership Will Benefit Healthcare Post Pandemic

Retrieved on: 
금요일, 6월 9, 2023
Korn Ferry, FRCS, Health, Physician, Health care, COVID-19, Healthgrades, MBA, Organization, Medicare, AAPL, U.S. News & World Report Best Hospitals Rankings, U.S. News & World Report, Hospital, American Association for Physician Leadership, Patient, FACS, Patient Centered Primary Care Collaborative, News, Nursing, Management, MD

WASHINGTON, June 9, 2023 /PRNewswire/ -- The American Association for Physician Leadership (AAPL) and Korn Ferry today issued a white paper, Preparing Physician Leaders for the Future , which highlights measurable ways that physician leadership benefits healthcare.

Key Points: 
  • WASHINGTON, June 9, 2023 /PRNewswire/ -- The American Association for Physician Leadership (AAPL) and Korn Ferry today issued a white paper, Preparing Physician Leaders for the Future , which highlights measurable ways that physician leadership benefits healthcare.
  • "Physician leaders are essential to healthcare leadership teams, and their expertise has been embraced by their leadership colleagues in finance, human resources, and other administrative positions.
  • The importance of their role was underscored during the COVID-19 pandemic, when patients and the public relied foremost on physician leaders for guidance to navigate the crisis," the white paper states.
  • Non- physician healthcare executives have welcomed physician leaders into their ranks, and top-performing organizations recognize the need for more physician leaders.

Concurrent Technologies Corporation to Continue Efforts to Improve Marine Corps Energy Resiliency

Retrieved on: 
금요일, 6월 2, 2023
Workforce, Marine Corps Systems Command, FRCS, RMC, Community of practice, Research, Plant, CTC, Community, Marine, Marines, Policy, MCICOM, Construction, Risk management, Architecture

Johnstown, PA, June 02, 2023 (GLOBE NEWSWIRE) -- The U.S. Marine Corps Installations Command (MCICOM) has awarded Option Year 2 of the Facility Related Controls Systems (FRCS) Programmatic Support Contract to Concurrent Technologies Corporation (CTC).

Key Points: 
  • Johnstown, PA, June 02, 2023 (GLOBE NEWSWIRE) -- The U.S. Marine Corps Installations Command (MCICOM) has awarded Option Year 2 of the Facility Related Controls Systems (FRCS) Programmatic Support Contract to Concurrent Technologies Corporation (CTC).
  • The Marine Corps FRCS program consists of 350+ networked systems, including utilities, fueling, fire and life safety, electronic security, and several other platforms associated with the operation of an installation.
  • “We are excited to continue supporting the Marine Corps mission.
  • “Our team of experts are building on our rich history to help secure and operationalize the Marine Corps.”
    Concurrent Technologies Corporation (CTC) is an independent, nonprofit, applied scientific research and development professional services organization.

Penumbra Expands Computer-Aided Thrombectomy Offerings with Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration

Retrieved on: 
목요일, 6월 1, 2023
Columbia University, Columbia University Irving Medical Center, Maxident, Lightning, FRCS, Amputation, ALI, Quality of life, CIS, Artery, Libin Cardiovascular Institute, Friction, MD, Patient, Physician, FACS, Buerger's test, Mortality, FDA, Regulation of tobacco by the U.S. Food and Drug Administration, NYSE, Food, Pharmaceutical industry, Birth control

Lightning Bolt 7 introduces a new method for removing blood clots, modulated aspiration, which pairs Penumbra's Lightning Intelligent Aspiration technology with an advanced microprocessor algorithm.

Key Points: 
  • Lightning Bolt 7 introduces a new method for removing blood clots, modulated aspiration, which pairs Penumbra's Lightning Intelligent Aspiration technology with an advanced microprocessor algorithm.
  • When used together, Lightning Bolt 7 is designed to enhance the ability to rapidly remove large, fibrous blood clots in the arteries with minimal blood loss, addressing conditions such as acute limb ischemia (ALI), hibernating thrombus and visceral occlusions.
  • "Advancements like Lightning Bolt 7 provide a critical frontline option for physicians to treat patients and improve patient outcomes."
  • Powered by the Penumbra ENGINE®, Lightning Bolt 7 is engineered to detect the difference between blood clot and blood flow.

Peptilogics Reports Positive 90-Day Top Line Interim Data From Phase 1b Trial of PLG0206 in Patients With Periprosthetic Joint Infection (PJI)

Retrieved on: 
수요일, 5월 24, 2023
Biotechnology, Health, General Health, Pharmaceutical, Medical Devices, Research, Infectious Diseases, Hospitals, Surgery, Science, Clinical Trials, Insurance, CARB-X, Biomedical Advanced Research and Development Authority, FRCS, Failure, Office of Inspector General, U.S. Department of Health and Human Services, Human services, Wellcome Trust, Administration for Strategic Preparedness and Response, Doctor of Philosophy, Șaeș, Administration, Development, SAE, Hospital, Journal, TKA, Patient, Thomas Jefferson University Hospital, Bacteria, Orthopedic surgery, Biofilm, Economics, Pharmaceutical industry, Arthroplasty, MD

Peptilogics, a clinical-stage biotechnology company, today announced top-line interim data of PLG0206 in PJI patients from their ongoing Phase 1b trial.

Key Points: 
  • Peptilogics, a clinical-stage biotechnology company, today announced top-line interim data of PLG0206 in PJI patients from their ongoing Phase 1b trial.
  • At 90 days post-Debridement, Antibiotics, and Implant Retention (DAIR) surgery, there were no treatment-related adverse events reported in the low-dose cohort.
  • Detailed analyses along with data from the high-dose cohort will be presented at conferences in the coming months.
  • In the Phase 1b clinical trial, PLG0206 is being studied in patients undergoing DAIR for treatment of a PJI occurring after total knee arthroplasty (TKA).

AMERICAN ASSOCIATION FOR PHYSICIAN LEADERSHIP LAUNCHES "HEALTHCARE ADMINISTRATION LEADERSHIP AND MANAGEMENT JOURNAL" TO FOCUS ON THE NEW DEMANDS FACED BY PHYSICIAN AND NON-PHYSICIAN HEALTHCARE LEADERS

Retrieved on: 
화요일, 4월 11, 2023
Ascension St. Mary's Hospital, FRCS, Population health, Health, Information technology, Health policy, Malpractice, AAPL, Journal, American Association for Physician Leadership, Physician, FACEP, FACS, Knowledge, Hospital, CPE, Management, Nursing, MD

WASHINGTON, April 11, 2023 /PRNewswire/ -- The American Association for Physician Leadership (AAPL) announced today the launch of their new journal dedicated to the evolving demands placed on physician and non-physician administrators of healthcare; the Healthcare Administration Leadership and Management (HALM) Journal.

Key Points: 
  • WASHINGTON, April 11, 2023 /PRNewswire/ -- The American Association for Physician Leadership (AAPL) announced today the launch of their new journal dedicated to the evolving demands placed on physician and non-physician administrators of healthcare; the Healthcare Administration Leadership and Management (HALM) Journal.
  • The HALM Journal will deliver results-oriented guidance for a healthcare industry moving towards inter-professional teams in a way that can create a positive impact on patient care outcomes and population health.
  • HALM Journal is a guide to sound fiscal practice, physician and non-physician leadership issues, human resources, health IT, patient-centric care, health law and malpractice topics, and secrets of the best-run healthcare practices.
  • "The HALM Journal will help facilitate this change process through the AAPL's community's robust network for collaboration and networking.

Vella Bioscience Inc. Granted First Patent For Use of Cannabinoids in Treating Antidepressant-Induced Female Sexual Dysfunction

Retrieved on: 
수요일, 3월 29, 2023
Patent, FRCS, Cannabinoid, Woman, Attitude, Science, Selective serotonin reuptake inhibitor, United States Patent and Trademark Office, Pleasure, Serotonin–norepinephrine reuptake inhibitor, Health, FDA, Female, Pharmaceutical industry, MD, CBD

NEW YORK, March 29, 2023 /PRNewswire/ -- Vella Bioscience Inc. whose Women's Pleasure Serum has been dubbed the "Women's Viagra®," has announced today that the Patent and Trademark Office (USPTO) has granted the brand's first patent. The patent is for the use of cannabinoids in treating Antidepressant-Induced Female Sexual Dysfunction.

Key Points: 
  • whose Women's Pleasure Serum has been dubbed the "Women's Viagra®," has announced today that the Patent and Trademark Office (USPTO) has granted the brand's first patent.
  • The patent is for the use of cannabinoids in treating Antidepressant-Induced Female Sexual Dysfunction.
  • As a company, we bring a certain 'the future-is-now' attitude to women's sexual empowerment and pleasure that is wholly unique."
  • Vella's patent establishes it as a pioneer in the clinical beauty space of female sexual health and wellness and proves its commitment to science and innovation.

Exactech and JointMedica Announce First Hip Resurfacing Procedure with Polymotion® Hip Implant

Retrieved on: 
화요일, 1월 10, 2023
Technology, Surgery, Medical Devices, Other Technology, Health Technology, Software, Biotechnology, Health, General Health, McMinn, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Pathology, Metal-insulator-metal, Surgeon, Food, Patient, FRCS, Acquisition, Multimedia, Invention, Powder metallurgy, Medical device, MD

Exactech , a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, is pleased to announce the first hip resurfacing surgery was successfully completed using the novel JointMedica Polymotion® hip implant that is based on a metal-on-polyethylene articulation.

Key Points: 
  • Exactech , a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, is pleased to announce the first hip resurfacing surgery was successfully completed using the novel JointMedica Polymotion® hip implant that is based on a metal-on-polyethylene articulation.
  • View the full release here: https://www.businesswire.com/news/home/20230110005732/en/
    Exactech and JointMedica Announce First Hip Resurfacing Procedure with Polymotion® Hip Implant (Photo: Business Wire)
    This surgery was performed by hip resurfacing specialist Jim MacKenzie, MD, in Calgary, Canada, who is also celebrating a milestone accomplishment of 20 years of completing hip resurfacing procedures.
  • The Polymotion hip implant addressed the unique pathology of the patient’s hip that could not be addressed with legacy, metal-on-metal hip resurfacing implants.
  • In fact, Sir John Charnley, the credited inventor of the modern total hip replacement, intuitively performed hip resurfacing in his initial cohort of hip arthritis patients [rather than total hip arthroplasty].

All Physicians Are Leaders: American Association for Physician Leadership to Debut Annual Conference in Chicago, Illinois June 9-11, 2023

Retrieved on: 
목요일, 12월 1, 2022
American Association for Physician Leadership, AAPL, Organization, Conference, Physician, Education, FACS, FRCS, Medicine, Management, MD

WASHINGTON, Dec. 1, 2022 /PRNewswire/ -- The American Association for Physician Leadership (AAPL) announced today a new event, an Annual Leadership Conference , that will convene the physician community with speakers, education, and networking dedicated to enhancing leadership skills.

Key Points: 
  • WASHINGTON, Dec. 1, 2022 /PRNewswire/ -- The American Association for Physician Leadership (AAPL) announced today a new event, an Annual Leadership Conference , that will convene the physician community with speakers, education, and networking dedicated to enhancing leadership skills.
  • "We look forward to providing a forum of education and thought leadership geared to enhancing physician leadership skills and expertise.
  • The AAPL Annual Leadership Conference will be held in Chicago, Illinois, June 9-11, 2023.
  • The American Association for Physician Leadership (AAPL) is focused on the personal transformation of all physicians, and through them the organizations they serve.

Physician Leadership Is More Valuable Than Ever

Retrieved on: 
목요일, 11월 10, 2022
Leadership, U.S. News & World Report, Learning, Organization, Association, FRCS, American Association for Physician Leadership, Chief executive officer, American Association, FACS, Physician, Patient, AAPL, CEO, News, Management, Medicine, MD

WASHINGTON, Nov. 10, 2022 /PRNewswire/ -- Changes in patient expectations as a result of the pandemic and the seismic disruption in the healthcare industry over several years are among several factors demonstrating that physician leadership is more valuable – and critically needed – than ever, according to a white paper published by the American Association for Physician Leadership (AAPL).

Key Points: 
  • A significant number of top-ranked hospitals including 7 of the top 10 as ranked by U.S. News and World Report are run by physicians, according to Physician Leadership: More Valuable Than Ever,written by Peter B. Angood, MD, FRCS(C), FACS, MCCM, FAAPL(Hon), president and CEO, AAPL.
  • "Clearly, the need for physician leadership is great, and the value it brings to healthcare organizations is significant.
  • Today, only a paucity of medical schools and residency programs provide a modicum exposure to leadership development for physicians.
  • The American Association for Physician Leadership (AAPL) is focused on the personal transformation of all physicians, and through them the organizations they serve.

AOFAS Annual Meeting 2022: Orthopaedic Research and Innovation in a Unique City

Retrieved on: 
월요일, 9월 26, 2022
Kepler, Pierce, Correction, Lists of diseases, Arthritis, Foot, American Orthopaedic Foot and Ankle Society, Annual general meeting, Poster, Health, Deformity, Proceedings of the Human Factors and Ergonomics Society Annual Meeting, Partnership, Patient, Trauma, Löfgren, Female, Injury, Grey matter, Arthritis Foundation, OBE, FRCS, Leadership, Ankle, Diagnosis, Moderate, Arthrodesis, Research, GLOBE, Orthopedic surgery, Education, Society, Medicine, Dentistry, MD

Rosemont, Ill., Sept. 26, 2022 (GLOBE NEWSWIRE) -- More than 900 foot and ankle orthopaedic surgeons, advanced health practitioners, orthopaedic residents, and medical students attended the American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting on September 14-17, 2022.

Key Points: 
  • Rosemont, Ill., Sept. 26, 2022 (GLOBE NEWSWIRE) -- More than 900 foot and ankle orthopaedic surgeons, advanced health practitioners, orthopaedic residents, and medical students attended the American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting on September 14-17, 2022.
  • Also at the Annual Meeting, AOFAS and the Arthritis Foundation announced an exciting new collaboration, the Ankle Arthritis Think Tank.
  • Watch the AOFAS presidential remarks and the Orthopaedic Foot & Ankle Foundation update recorded live on the AOFAS Facebook Page .
  • The American Orthopaedic Foot & Ankle Society (AOFAS) mobilizes our dynamic community of foot and ankle orthopaedic surgeons to improve patient care through education, research, and advocacy.